California Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 131 (75% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 61,031
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 81.50%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 4,268
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 83.99%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 16.89% 14.41%
White, Hispanic/Latino Patients 49.07% 54.29%
Black/African American, Non-Hispanic/Latino Patients 4.65% 3.80%
Black/African American, Hispanic/Latino Patients 0.49% 0.49%
Asian Patients3 3.61% 2.23%
American Indian/Alaska Native Patients3 0.56% 0.59%
Native Hawaiian/Other Pacific Islander Patients3 0.45% 0.45%
Patients with More than one race3 3.87% 2.67%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 11.74% 11.11%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.41% 5.27%
Unreported/Refused to Report Race and Ethnicity 6.26% 4.71%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 19,412
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 89.50%
COVID-19 Immunization Series Completed 22,614
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 88.42%
COVID-19 Immunization Series Additional 15,299
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 74.97%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 9.28% 10.28% 22.45%
White, Hispanic/Latino Patients 40.16% 39.78% 18.98%
Black/African American, Non-Hispanic/Latino Patients 7.38% 6.78% 5.02%
Black/African American, Hispanic/Latino Patients 1.10% 1.70% 0.68%
Asian Patients3 5.02% 5.54% 26.52%
American Indian/Alaska Native Patients3 0.44% 0.57% 0.73%
Native Hawaiian/Other Pacific Islander Patients3 0.79% 0.51% 0.54%
Patients with More than one race3 4.16% 5.15% 3.82%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 20.10% 18.43% 10.95%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.62% 2.41% 2.75%
Unreported/Refused to Report Race and Ethnicity 8.94% 8.86% 7.56%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 7.63%
1 to 24 Hours 23.66%
More Than 24 Hours 64.89%
N/A 3.82%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 11.45%
Staffing to administer the vaccine 29.01%
Vaccine confidence 42.75%
Vaccine storage capacity 2.29%
Vaccine supply 3.82%
Other 7.63%
None 27.48%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 38.17%
Average Percent of Health Center Visits Conducted Virtually 35.04%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 35.88%
Number of Mobile Van Sites 126
Number of Pop-up Clinics 230
Number of School-Based Vaccination Sites 116

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 6.11%
Refer patients to another organization that provides monoclonal antibody therapies 42.75%
None 52.67%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 16.03%
Patient awareness/education 12.21%
Staffing capacity 20.61%
Therapy administration/onsite logistics 24.43%
Other 12.98%
None 47.33%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021